Status:
COMPLETED
Exploratory Study Using Nanotechnology to Detect Biomarkers of Parkinson's Disease From Exhaled Breath
Lead Sponsor:
Rambam Health Care Campus
Collaborating Sponsors:
Technion, Israel Institute of Technology
Conditions:
Parkinson's Disease
Parkinsonism
Eligibility:
All Genders
30+ years
Brief Summary
Parkinson's disease is diagnosed clinically, because biomarkers that may help in diagnosis and differential diagnosis are not yet available. Exhaled breath testing may yield a "breath-print" that can ...
Eligibility Criteria
Inclusion
- Patients with Parkinsonism
Exclusion
- Severe dementia
Key Trial Info
Start Date :
August 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2012
Estimated Enrollment :
41 Patients enrolled
Trial Details
Trial ID
NCT01246336
Start Date
August 1 2009
End Date
January 1 2012
Last Update
October 31 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.